Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMP: Amitriptyline and Topiramate for Pediatric Migraine Prevention
NCT01581281Phase 3Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Amitriptyline, Topiramate and Placebo (3 arms). Primary endpoint: Percentage of Participants Reporting a 50% or Greater Reduction in Headache Days at 24 weeks. Started Jun 2012; status: terminated.
02
Drugs
amitriptylinetopiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01581281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581281.